Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Nivo & Ipil Combo vs Placebo in Pts w/ Local Renal Cell Carcin who Underwent Radical or Partial Neph

Protocol: OSU-17156

Full Title

A Phase III Randomized Study Comparing Nivolumab and Ipilimumab Combination vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse